𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toxicity of Oxaliplatin Plus Fluorouracil/Leucovorin Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer: A Population-Based Study

✍ Scribed by Hamza, Samia; Bouvier, Anne-Marie; Rollot, Fabien; Lepage, Côme; Faivre, Jean; Bedenne, Laurent

Book ID
125405953
Publisher
Springer
Year
2014
Tongue
English
Weight
254 KB
Volume
21
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant chemotherapy with oxaliplatin,
Adjuvant chemotherapy with oxaliplatin, in combination with fluorouracil plus leucovorin prolongs disease-free survival, but causes more adverse events in people with stage II or III colon cancer: Abstracted from: André T, Boni C, Mounedji-Boudiaf L, et al. Multicenter international study of oxaliplatin/5-fluorouracil/leucovorin in the adjuvant treatment of colon cancer (MOSAIC) investigators. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004;350:2343–51
📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 213 KB
Severe enteropathy among patients with s
Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis
✍ J. Philip Kuebler; Linda Colangelo; Michael J. O'Connell; Roy E. Smith; Greg Yot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## BACKGROUND. Cases of severe gastrointestinal toxicity were monitored prospectively during NSABP C‐07, a randomized clinical trial of adjuvant therapy for patients with stage II/III colon cancer. ## METHODS. Patients were treated with weekly bolus 5‐fluorouracil (5‐FU) and leucovor